What does APOTHEEK VAN REETH - DEPROST do?

APOTHEEK VAN REETH - DEPROST is a pharmacy in Antwerpen. Private Limited, started on 27 April 1995, 1 establishment.

What is the address of APOTHEEK VAN REETH - DEPROST?

The registered office of APOTHEEK VAN REETH - DEPROST is located at Grotesteenweg 241, 2600 Antwerpen.

Is APOTHEEK VAN REETH - DEPROST still active?

Yes. According to the CBE (2 October 2026) APOTHEEK VAN REETH - DEPROST is active, legal situation “Normale toestand”, started on 27 April 1995.

Is APOTHEEK VAN REETH - DEPROST registered on Peppol?

Yes, APOTHEEK VAN REETH - DEPROST is registered on the Peppol network with ID 0208:0455125384.

What is the enterprise number of APOTHEEK VAN REETH - DEPROST?

The enterprise number of APOTHEEK VAN REETH - DEPROST is BE0455125384.

When was APOTHEEK VAN REETH - DEPROST founded?

APOTHEEK VAN REETH - DEPROST was founded on 27 April 1995.

Who are the directors of APOTHEEK VAN REETH - DEPROST?

According to the 2025 annual accounts, the directors of APOTHEEK VAN REETH - DEPROST are: Philippe Van Reeth, Caroline Deprost.

Is APOTHEEK VAN REETH - DEPROST a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 April 1995; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did APOTHEEK VAN REETH - DEPROST make in 2025?

APOTHEEK VAN REETH - DEPROST posted a profit after taxes of € 35,844 in financial year 2025.

What is the revenue of APOTHEEK VAN REETH - DEPROST?

As a small company, APOTHEEK VAN REETH - DEPROST is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 98,219.

How many employees does APOTHEEK VAN REETH - DEPROST have?

According to the 2025 annual accounts, APOTHEEK VAN REETH - DEPROST has 0.7 full-time equivalents (FTE).

APOTHEEK VAN REETH - DEPROST (Private Limited)

Dossier APOTHEEK VAN REETH - DEPROST, printed on 2 October 2026 from databakkes.be/en/0455125384/apotheek-van-reeth-deprost. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK VAN REETH - DEPROST from Antwerpen, company number BE0455125384, closed financial year 2025 with a result of € 35,844 after tax. For that financial year APOTHEEK VAN REETH - DEPROST recorded a gross margin of € 98,219 and equity of € 251,034. Compared with financial year 2024, the result moved from € 32,879 to € 35,844. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.

What it is worth Growing

€ 251,034

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 35,844

▲ 9% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 69,038

▼ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 10,206 paid out

28 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

0.7

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 35,891

▲ 1% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 2,685

▼ 26% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 4,562

▼ 76% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 32,814

▼ 30% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 9,163

▼ 19% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 47,258 Gross margin 2022: € 47,258 First fiscal year in the series	€ 72,310 Gross margin 2023: € 72,310 ▲ 53% vs 2022 (€ 47,258) Favourable step	€ 105,384 Gross margin 2024: € 105,384 ▲ 46% vs 2023 (€ 72,310) Favourable step	€ 98,219 Gross margin 2025: € 98,219 ▼ 7% vs 2024 (€ 105,384) Unfavourable step	▼ 7%
Profit after taxes	€ -7,907 Profit after taxes 2022: € -7,907 First fiscal year in the series	€ 12,188 Profit after taxes 2023: € 12,188 ▲ € 20,095 vs 2022 (€ -7,907) Favourable step	€ 32,879 Profit after taxes 2024: € 32,879 ▲ 170% vs 2023 (€ 12,188) Favourable step	€ 35,844 Profit after taxes 2025: € 35,844 ▲ 9% vs 2024 (€ 32,879) Favourable step	▲ 9%
Equity	€ 249,434 Equity 2022: € 249,434 First fiscal year in the series	€ 213,221 Equity 2023: € 213,221 ▼ 15% vs 2022 (€ 249,434) Unfavourable step	€ 225,395 Equity 2024: € 225,395 ▲ 6% vs 2023 (€ 213,221) Favourable step	€ 251,034 Equity 2025: € 251,034 ▲ 11% vs 2024 (€ 225,395) Favourable step	▲ 11%
Total debts	€ 211,176 Total debts 2022: € 211,176 First fiscal year in the series	€ 183,158 Total debts 2023: € 183,158 ▼ 13% vs 2022 (€ 211,176) Favourable step	€ 133,732 Total debts 2024: € 133,732 ▼ 27% vs 2023 (€ 183,158) Favourable step	€ 85,754 Total debts 2025: € 85,754 ▼ 36% vs 2024 (€ 133,732) Favourable step	▼ 36%
Cash	€ 83,021 Cash 2022: € 83,021 First fiscal year in the series	€ 82,680 Cash 2023: € 82,680 Unchanged (€ 83,021) Unfavourable step	€ 71,494 Cash 2024: € 71,494 ▼ 14% vs 2023 (€ 82,680) Unfavourable step	€ 69,038 Cash 2025: € 69,038 ▼ 3% vs 2024 (€ 71,494) Unfavourable step	▼ 3%
Retained profit	€ 230,842 Retained profit 2022: € 230,842 First fiscal year in the series	€ 194,629 Retained profit 2023: € 194,629 ▼ 16% vs 2022 (€ 230,842) Unfavourable step	€ 206,803 Retained profit 2024: € 206,803 ▲ 6% vs 2023 (€ 194,629) Favourable step	€ 232,442 Retained profit 2025: € 232,442 ▲ 12% vs 2024 (€ 206,803) Favourable step	▲ 12%
Dividend	€ 38,749 Dividend 2022: € 38,749 First fiscal year in the series	€ 48,401 Dividend 2023: € 48,401 ▲ 25% vs 2022 (€ 38,749) Unchanged	€ 20,705 Dividend 2024: € 20,705 ▼ 57% vs 2023 (€ 48,401) Unchanged	€ 10,206 Dividend 2025: € 10,206 ▼ 51% vs 2024 (€ 20,705) Unchanged	▼ 51%
Bank debt	€ 72,187 Bank debt 2022: € 72,187 First fiscal year in the series	€ 45,920 Bank debt 2023: € 45,920 ▼ 36% vs 2022 (€ 72,187) Favourable step	€ 19,358 Bank debt 2024: € 19,358 ▼ 58% vs 2023 (€ 45,920) Favourable step	€ 4,562 Bank debt 2025: € 4,562 ▼ 76% vs 2024 (€ 19,358) Favourable step	▼ 76%
Balance sheet total	€ 460,610 Balance sheet total 2022: € 460,610 First fiscal year in the series	€ 396,379 Balance sheet total 2023: € 396,379 ▼ 14% vs 2022 (€ 460,610) Unchanged	€ 359,127 Balance sheet total 2024: € 359,127 ▼ 9% vs 2023 (€ 396,379) Unchanged	€ 336,788 Balance sheet total 2025: € 336,788 ▼ 6% vs 2024 (€ 359,127) Unchanged	▼ 6%
Employees (FTE)	0.7 Employees (FTE) 2022: 0.7 First fiscal year in the series	0.7 Employees (FTE) 2023: 0.7 Unchanged (0.7) Unchanged	0.7 Employees (FTE) 2024: 0.7 Unchanged (0.7) Unchanged	0.7 Employees (FTE) 2025: 0.7 Unchanged (0.7) Unchanged

Key figures of APOTHEEK VAN REETH - DEPROST, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK VAN REETH - DEPROST?

What happened at APOTHEEK VAN REETH - DEPROST in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 19, 2026 New annual accounts for financial year 2025: profit of € 35,844 (▲ 9% vs 2024). Source: NBB ↗
Jul 3, 1995 New establishment in Antwerpen. KBO
Apr 27, 1995 Start of the company according to the CBE. KBO

In short

From € 7,908 loss in 2022 to € 35,844 profit in 2025.

Paid € 21,504 in corporate taxes since 2022.

Best year ever: 2025, with € 35,844 profit.

Paid out € 118,060 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at APOTHEEK VAN REETH - DEPROST? We notify you, reason included.

Follow APOTHEEK VAN REETH - DEPROST

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Philippe Van Reeth Caroline Deprost

APOTHEEK VAN REETH - DEPROST

Behind APOTHEEK VAN REETH - DEPROST are Philippe Van Reeth and Caroline Deprost.

See the full network in the app

Directors

According to the 2025 annual accounts

Philippe Van Reeth

Bestuurder

Caroline Deprost

Bestuurder

Establishments

Establishment units

Physical locations of this company

Registered office

Grotesteenweg 241

2600 Antwerpen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0455.125.384

VAT number

BE 0455.125.384

Registered office

Grotesteenweg 241, 2600 Antwerpen

Names & denominations

APOTHEEK VAN REETH - DEPROST

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

27 April 1995

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VAN REETH - DEPROST

Financials

What happened to APOTHEEK VAN REETH - DEPROST?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions